Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Supply Chain Blueprint
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Menu
New White Paper
- Read AAM Report on Drug Shortages
Learn More
Close
Breadcrumb
Home
AAM Founders Series
AAM Founders Series
Share
We’re profiling the founders of the industry, view below to read all of their stories.
Listen to Their Stories
Blog
May 13, 2020
| Bob Billings
Thank You, Bill Haddad
Blog
Jun 16, 2020
| Bob Billings
Thank you, Agnes Varis
Blog
Jun 26, 2020
| Bob Billings
Thank you, Desh Bandhu Gupta
Blog
Jul 30, 2020
| Bob Billings
Thank you, Carole Ben-Maimon
Blog
Sep 24, 2020
| Bob Billings
Thank you, Rep. Henry Waxman
Blog
Oct 23, 2020
| Bob Billings
Thank you, Mike Puskar
Blog
Jan 4, 2021
| Bob Billings
Thank you, Jean Hoffman
Blog
Jul 1, 2021
| Bob Billings
Thank you, Eli Hurvitz
Blog
Sep 21, 2021
| Bob Billings
Thank you, Kanu Patel
Blog
Dec 14, 2021
| Bob Billings
Thank you, Ramprasad Reddy
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
GRx+Biosims 2022
Access! 2022
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Supply Chain Blueprint
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action